| Dr Wajdi S Kfoury, MD | |
|
1 Trillium Way, Corbin, KY 40701-8727 | |
| (606) 526-4449 | |
| (606) 523-8581 |
| Full Name | Dr Wajdi S Kfoury |
|---|---|
| Gender | Male |
| Speciality | Infectious Disease |
| Experience | 26 Years |
| Location | 1 Trillium Way, Corbin, Kentucky |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124010814 | NPI | - | NPPES |
| 000000358174 | Other | KY | BCBS- EBMC LOC. |
| 000000521524 | Other | KY | BCBS-KFOURY MED SPEC. LOC |
| 64089154 | Medicaid | KY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RI0200X | Internal Medicine - Infectious Disease | 38881 (Kentucky) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Baptist Health Corbin | Corbin, KY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Baptist Health Medical Group Inc | 5597867184 | 1912 |
News Archive
More than a year-and-a-half after the onset of the COVID-19 pandemic, the scientific community is still feeling the effects of the vastly disruptive event -; and may for many years to come.
Last month, an article in the journal Health Affairs made headlines in the news media -; "Physicians Are Not Always Open or Honest with Patients." A vast majority of the nearly 2,000 doctors surveyed agreed that physicians should be fully open and honest in all their communications with patients. ... I suspect that the dishonesty that is being uncovered in a study such as this -; and frankly, I was amazed that the number of less-than-truthful instances was so low -; reveals more about the diagnosis of being human than anything else. ... I couldn't bring myself to tell this young mother that she was going to die."
Universal Detection Technology, a developer of early-warning monitoring technologies and counter-terrorism training programs to protect people from bioterrorism and other infectious health threats, announced today that it will be showcasing its TS-10-5-agent biodetection kit at ASIS International 2009 in Anaheim, California.
PositiveID Corporation, in conjunction with its development partner RECEPTORS LLC, announced today that the companies have achieved a milestone in the development of their in vivo glucose-sensing RFID microchip to detect glucose levels in the body. The companies have completed the synthesis of a new chemical building block that will serve as the anchor of their next generation of Combinatorial Artificial Receptor (CARA™) surfaces for the sensing system component of the implantable glucose sensor.
Raptor Pharmaceuticals Corp. has announced that its clinical development subsidiary, Bennu Pharmaceuticals Inc. , has initiated the Company's first clinical-stage program after dosing the first cohort in a Phase IIa study of oral 4-methylpyrazole ("4-MP") in subjects with ALDH2 deficiency, or ethanol intolerance, as the initial development stage of its Convivia program.
› Verified 9 days ago
| Entity Name | Kfoury Medical Specialists Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093833998 PECOS PAC ID: 1759482250 Enrollment ID: O20070727000665 |
News Archive
More than a year-and-a-half after the onset of the COVID-19 pandemic, the scientific community is still feeling the effects of the vastly disruptive event -; and may for many years to come.
Last month, an article in the journal Health Affairs made headlines in the news media -; "Physicians Are Not Always Open or Honest with Patients." A vast majority of the nearly 2,000 doctors surveyed agreed that physicians should be fully open and honest in all their communications with patients. ... I suspect that the dishonesty that is being uncovered in a study such as this -; and frankly, I was amazed that the number of less-than-truthful instances was so low -; reveals more about the diagnosis of being human than anything else. ... I couldn't bring myself to tell this young mother that she was going to die."
Universal Detection Technology, a developer of early-warning monitoring technologies and counter-terrorism training programs to protect people from bioterrorism and other infectious health threats, announced today that it will be showcasing its TS-10-5-agent biodetection kit at ASIS International 2009 in Anaheim, California.
PositiveID Corporation, in conjunction with its development partner RECEPTORS LLC, announced today that the companies have achieved a milestone in the development of their in vivo glucose-sensing RFID microchip to detect glucose levels in the body. The companies have completed the synthesis of a new chemical building block that will serve as the anchor of their next generation of Combinatorial Artificial Receptor (CARA™) surfaces for the sensing system component of the implantable glucose sensor.
Raptor Pharmaceuticals Corp. has announced that its clinical development subsidiary, Bennu Pharmaceuticals Inc. , has initiated the Company's first clinical-stage program after dosing the first cohort in a Phase IIa study of oral 4-methylpyrazole ("4-MP") in subjects with ALDH2 deficiency, or ethanol intolerance, as the initial development stage of its Convivia program.
› Verified 9 days ago
| Entity Name | Baptist Health Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518360296 PECOS PAC ID: 5597867184 Enrollment ID: O20150206000249 |
News Archive
More than a year-and-a-half after the onset of the COVID-19 pandemic, the scientific community is still feeling the effects of the vastly disruptive event -; and may for many years to come.
Last month, an article in the journal Health Affairs made headlines in the news media -; "Physicians Are Not Always Open or Honest with Patients." A vast majority of the nearly 2,000 doctors surveyed agreed that physicians should be fully open and honest in all their communications with patients. ... I suspect that the dishonesty that is being uncovered in a study such as this -; and frankly, I was amazed that the number of less-than-truthful instances was so low -; reveals more about the diagnosis of being human than anything else. ... I couldn't bring myself to tell this young mother that she was going to die."
Universal Detection Technology, a developer of early-warning monitoring technologies and counter-terrorism training programs to protect people from bioterrorism and other infectious health threats, announced today that it will be showcasing its TS-10-5-agent biodetection kit at ASIS International 2009 in Anaheim, California.
PositiveID Corporation, in conjunction with its development partner RECEPTORS LLC, announced today that the companies have achieved a milestone in the development of their in vivo glucose-sensing RFID microchip to detect glucose levels in the body. The companies have completed the synthesis of a new chemical building block that will serve as the anchor of their next generation of Combinatorial Artificial Receptor (CARA™) surfaces for the sensing system component of the implantable glucose sensor.
Raptor Pharmaceuticals Corp. has announced that its clinical development subsidiary, Bennu Pharmaceuticals Inc. , has initiated the Company's first clinical-stage program after dosing the first cohort in a Phase IIa study of oral 4-methylpyrazole ("4-MP") in subjects with ALDH2 deficiency, or ethanol intolerance, as the initial development stage of its Convivia program.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Wajdi S Kfoury, MD Po Box 182, Corbin, KY 40702-0182 Ph: (606) 767-1577 | Dr Wajdi S Kfoury, MD 1 Trillium Way, Corbin, KY 40701-8727 Ph: (606) 526-4449 |
News Archive
More than a year-and-a-half after the onset of the COVID-19 pandemic, the scientific community is still feeling the effects of the vastly disruptive event -; and may for many years to come.
Last month, an article in the journal Health Affairs made headlines in the news media -; "Physicians Are Not Always Open or Honest with Patients." A vast majority of the nearly 2,000 doctors surveyed agreed that physicians should be fully open and honest in all their communications with patients. ... I suspect that the dishonesty that is being uncovered in a study such as this -; and frankly, I was amazed that the number of less-than-truthful instances was so low -; reveals more about the diagnosis of being human than anything else. ... I couldn't bring myself to tell this young mother that she was going to die."
Universal Detection Technology, a developer of early-warning monitoring technologies and counter-terrorism training programs to protect people from bioterrorism and other infectious health threats, announced today that it will be showcasing its TS-10-5-agent biodetection kit at ASIS International 2009 in Anaheim, California.
PositiveID Corporation, in conjunction with its development partner RECEPTORS LLC, announced today that the companies have achieved a milestone in the development of their in vivo glucose-sensing RFID microchip to detect glucose levels in the body. The companies have completed the synthesis of a new chemical building block that will serve as the anchor of their next generation of Combinatorial Artificial Receptor (CARA™) surfaces for the sensing system component of the implantable glucose sensor.
Raptor Pharmaceuticals Corp. has announced that its clinical development subsidiary, Bennu Pharmaceuticals Inc. , has initiated the Company's first clinical-stage program after dosing the first cohort in a Phase IIa study of oral 4-methylpyrazole ("4-MP") in subjects with ALDH2 deficiency, or ethanol intolerance, as the initial development stage of its Convivia program.
› Verified 9 days ago
Dr. Swati Yalamanchi, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1 Trillium Way, Baptist Health Cancer Center, Corbin, KY 40701 Phone: 606-523-1934 Fax: 606-523-1982 | |
Dr. Daniel W Whitley, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1419 Cumberland Falls Hwy, Corbin, KY 40701 Phone: 606-528-4481 Fax: 606-528-2857 | |
Dr. John P. Loventhal, MD Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 45 Moonbow Plz, Corbin, KY 40701 Phone: 606-523-9010 Fax: 606-528-0028 | |
Dr. Pramod A Reddy, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 45 Moonbow Plz, Corbin, KY 40701 Phone: 606-523-9010 Fax: 606-523-5923 | |
Priyanka Srinivas, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 2 Trillium Way Ste 306, Corbin, KY 40701 Phone: 606-526-4070 Fax: 606-526-4072 | |
Mr. William R Durham, MD Infectious Disease Medicare: Medicare Enrolled Practice Location: 513 18th St, Corbin, KY 40701 Phone: 606-526-9664 Fax: 606-526-6263 | |
Jeremy Swiney, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1 Trillium Way, Corbin, KY 40701 Phone: 606-528-1212 |